Once IPIX has licensed Brilacidin to a partner for
Post# of 72440
(Total Views: 268)
Posted On: 02/24/2019 9:11:12 PM
Once IPIX has licensed Brilacidin to a partner for a specific indication, can that partner market the drug with a name of their choosing or do they have to refer it as Brilacidin-OM, Brilacidin-IBD, Brilacidin-Crohn's, or some such name?
If IPIX was to license the entire Brilacidin platform to one BP, this would become a moot point because all their marketing across many medical indications would build the name recognition of B and IMO allow later indications to be accepted more quickly by the public. I see Humira currently following this marketing plan.
But if IPIX partners w/ multiple BPs, many may not want to do more than their fair share of marketing if all the others will benefit by doing very little. Feedback appreciated.
I personally would like to see the Brilacidin name out there in print, TV, etc as often as possible.
If IPIX was to license the entire Brilacidin platform to one BP, this would become a moot point because all their marketing across many medical indications would build the name recognition of B and IMO allow later indications to be accepted more quickly by the public. I see Humira currently following this marketing plan.
But if IPIX partners w/ multiple BPs, many may not want to do more than their fair share of marketing if all the others will benefit by doing very little. Feedback appreciated.
I personally would like to see the Brilacidin name out there in print, TV, etc as often as possible.
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼